Content about Endo Pharmaceuticals

May 13, 2013
FDA ruling on opioid painkiller deals blow to Endo

A ruling by the Food and Drug Administration means that generic versions of an opioid painkiller made by Endo Pharmaceuticals can stay on the market, drawing criticism from the drug maker.

April 16, 2013
Authorities worry about abuse potential as OxyContin patent expires

Purdue Pharma's patent for OxyContin expired Tuesday, opening up the opioid painkiller to generic competition, but authorities have raised concerns about what they call the potential for generic versions to be abused.

March 5, 2013
Actavis seeks approval for testosterone-replacement gel

Drug maker Actavis is challenging the patent for a drug used to treat testosterone deficiency or absence in men, the company said.

January 9, 2013
WEB FEATURE: FDA guidance aims to encourage abuse-deterrent painkillers

One of the most serious drug abuse problems in the country doesn't involve heroin, methamphetamine or crack, but abuse of legal prescription drugs, particularly opioid painkillers, a problem that the Food and Drug Administration aims to change with draft guidance released Wednesday.

December 21, 2012
Federal court rules against Endo in painkiller case

A federal court decision means that a nontamper-resistant formulation of a painkiller made by Endo Health Solutions can enter the market early next month, the drug maker said.

August 24, 2012
FDA approves Watson pain patch

The Food and Drug Administration has approved a generic medicated patch for treating pain made by Watson Pharmaceuticals, the company said.

May 29, 2012
Watson settles with Endo, Teikoku Seiyaku over generic version of Lidoderm patch

Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.

May 24, 2012
Endo parent company changes name to Endo Health Solutions Inc.

The parent company of Endo Pharmaceuticals has changed its name, the company said.

March 14, 2012
Endo seeks tougher standards for generic versions of Lidoderm

Endo Pharmaceuticals is hoping the Food and Drug Administration will back tougher regulatory approval requirements for generic versions of one of its drugs.

March 1, 2012
Endo integrates business units, plans name change

Endo's parent company is looking to change its name and will integrate four of its operating units, the drug maker said Thursday.

January 9, 2012
Endo addresses possible short-term supply of Opana ER, other drugs

Endo Pharmaceuticals announced a short-term supply constraint of analgesic products, including Opana ER, due to the temporary shutdown of a manufacturing facility operated by Novartis Consumer Health.

December 12, 2011
FDA approves crush-resistant painkiller by Endo

The Food and Drug Administration has approved a new formulation of a painkiller made by Endo Pharmaceuticals designed to thwart drug abuse, Endo said Monday.

November 2, 2011
FDA approves Endo generic Plendil

The Food and Drug Administration has approved a drug made by Endo Pharmaceuticals for high blood pressure.

September 16, 2011
Endo subsidiary announces nationwide recall of birth control

Qualitest Pharmaceuticals, an Endo Pharmaceuticals subsidiary, issued a voluntary, nationwide recall of multiple lots of oral contraceptives at the retail level.

August 18, 2011
Endo ends axomadol collaboration with Grunenthal

Endo Pharmaceuticals has ended its research program and collaboration with Grunenthal.

August 17, 2011
Mylan seeks approval for generic migraine drug

Mylan announced Wednesday that it filed with the Food and Drug Administration for approval of a generic version of a drug for migraine headaches made by Endo Pharmaceuticals.

June 24, 2011
FDA accepts Endo's resubmission for Opana ER

The Food and Drug Administration has accepted a resubmission by Endo Pharmaceuticals of a regulatory application for an opioid pain drug designed to thwart abuse, Endo said.

June 22, 2011
Endo completes acquisition of American Medical Systems

Endo Pharmaceuticals has acquired a provider of devices and therapies for male and female pelvic health.

May 23, 2011
ReportersNotebook — Chain Pharmacy, 5/30/11

The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


May 5, 2011
Mylan launches generic Percodan

A generic drug maker has launched its version of a pain medication made by Endo Pharmaceuticals.

April 11, 2011
Endo to acquire American Medical Systems

Endo Pharmaceuticals will buy American Medical Systems for $2.9 billion, the drug maker said Monday.

March 4, 2011
Oral contraceptive Emoquette wins FDA approval

A subsidiary of Endo Pharmaceuticals has won approval from the Food and Drug Administration for an oral contraceptive.

March 3, 2011
Endo launches Fortesta

Endo Pharmaceuticals has launched a recently approved testosterone gel for men.

January 31, 2011
Mylan looks to market generic Lidoderm

Mylan has announced its intention to market a version of a painkiller made by Endo Pharmaceuticals and partner company Teikoku Seiyaku ahead of patent expiration.

January 10, 2011
Endo receives complete response letter for crush-resistant Opana ER

The Food and Drug Administration declined to approve Endo Pharmaceuticals’ regulatory application for a painkiller designed to thwart drug abusers, Endo said Friday.

© 2013 Drug Store News. All Rights Reserved.